Investor's Business Daily on MSN
IBD stock of the day: Ligand Pharma, biotech's royalty arm, breaks out
Ligand Pharmaceuticals is Tuesday's IBD Stock Of The Day. The biotech stock has blown past several buy points on its way to a new breakout.
Investor's Business Daily on MSN
Amprius Technologies gets IBD stock rating upgrade
The IBD SmartSelect Composite Rating for Amprius Technologies increased from 94 to 96 Monday.
根据Abivax的研究,2024年237亿美金的IBD药物市场由154亿美金的CD治疗药物以及83亿美金的UC治疗药物组成;到2030年,这一市场将增 ...
IU researchers have linked an age-related blood condition to inflammatory bowel disease (IBD) and identified a potential treatment to reduce the severity of inflammation-driven diseases.
Indiana University School of Medicine scientists have uncovered new evidence that an age-related blood condition may contribute to inflammatory bowel disease (IBD). Their findings suggest that a new ...
New ECCO dietary therapy guidelines for IBD clarify the role of enteral nutrition, Mediterranean diet, supplements, and RD ...
MedPage Today on MSN
Gastro Practice Settles for Nearly $5M; Acne and JAK Inhibitors; Prior Auth in IBD
News and commentary from the world of gastroenterology and hepatology ...
A team of scientists from the Indiana University School of Medicine has discovered a new link between an age-related blood condition and inflammatory bowel disease, often called IBD. Their research ...
Indiana University School of Medicine scientists have uncovered new evidence that an age-related blood condition may ...
Active IBD in older adults is linked to higher odds of cognitive decline over 1 year, and deficits in delayed recall signal an increased risk for active disease.
MedPage Today on MSN
Incidence of Bowel Disease in Kids Nearly Quadrupled Over 40 Years
Danish study also showed more extensive disease at diagnosis, earlier onset with family hi ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果